Therapeutic passive vaccination against chronic Lyme disease in mice.
about
Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implicationsTemporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and miceVector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticksStage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation.Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferiBorrelia burgdorferi erpT expression in the arthropod vector and murine host.Lyme arthritis resolution with antiserum to a 37-kilodalton Borrelia burgdorferi protein.Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato.DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodiesGenetic diversity of the outer surface protein C gene of southern Borrelia isolates and its possible epidemiological, clinical, and pathogenetic implications.Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors.Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato speciesConformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31.Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis.DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme diseaseGenetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto.Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferiImmunogenicity of Borrelia burgdorferi arthritis-related proteinAntibody-mediated disease remission in the mouse model of lyme borreliosis.The absence of linear plasmid 25 or 28-1 of Borrelia burgdorferi dramatically alters the kinetics of experimental infection via distinct mechanisms.Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice.An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitopeThe versatile roles of antibodies in Borrelia infections.An immune evasion mechanism for spirochetal persistence in Lyme borreliosis.Whole-genome DNA array analysis of the response of Borrelia burgdorferi to a bactericidal monoclonal antibody.Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice.SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure.Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection.Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.
P2860
Q24550721-0D1B34A3-6DD8-47F6-970D-A36315438E12Q24550778-2279293A-03E1-4633-87FD-09CE17CF8A81Q24646772-AB95F51D-436A-4567-9022-ED006D4BD99BQ27347664-FAD2B991-C600-4008-8062-AFF03898D497Q27629139-3D7DFF6F-36D2-4181-9DFA-21CD610A568FQ31906477-CA4B727B-4CCA-4549-88A5-752AA7D79ECBQ33597989-10AFEC30-8C77-4AFE-9556-577D206D26D7Q33767593-557217EE-7D06-4769-B25B-640C1D9061D8Q33767776-1FEDC167-BD66-46E8-A988-4D318ACF081CQ33959924-DB812655-40C2-46E6-9FEA-8DDB669AC786Q33974101-BABC5444-6674-4B2C-8658-4922DFFE6020Q33999873-780E3062-90F1-4FE7-A106-5C26E585E2CFQ34002237-145D79C5-7DF3-4E3B-A3D7-D410D0B30BCBQ34002242-28AA38D5-F0C6-403F-9087-44F14CFD1EC3Q34005057-06E2114E-3FE7-4B93-9263-7E1E13FF5E13Q34006707-A6A5B326-78D1-434D-8778-C73E11FA73D5Q34606054-2C669D38-FA0B-40DE-83CA-D62E32E88CBAQ34797227-C43CCEE3-6226-41BB-943B-91CE20FFCB0DQ34944212-AF56F865-263F-407A-B72B-E40F08495D9DQ34975726-1D452089-4E4A-4214-BD9E-8CE0B35F522FQ35165125-F5D050B7-6382-4884-B2DB-A5F4C4B99295Q35802349-1FB77434-D174-421B-8B65-94E09B60A772Q36017879-D30FD322-2857-4363-A01A-5EB7317CC3D4Q36111888-52ABBABD-9D33-4B7B-B7E8-7CD949BEA91CQ36369900-5F70BC32-3F0F-4098-AB4E-552158D2C50BQ37117273-1A221514-0DF0-4675-9901-35BAB71E18C4Q37712830-687E0611-B2F8-469F-9CE8-3B0259260D7CQ39118758-94ABEDA3-9523-473D-91A8-F616D7B35AEEQ41719890-AD26CEA0-D9EA-4DC6-810B-CB0433F2AD37Q45417527-44C7A39A-ACD3-41AC-9051-4986E4E22B49
P2860
Therapeutic passive vaccination against chronic Lyme disease in mice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Therapeutic passive vaccination against chronic Lyme disease in mice.
@en
type
label
Therapeutic passive vaccination against chronic Lyme disease in mice.
@en
prefLabel
Therapeutic passive vaccination against chronic Lyme disease in mice.
@en
P2093
P2860
P356
P1476
Therapeutic passive vaccination against chronic Lyme disease in mice.
@en
P2093
C Museteanu
P2860
P304
12533-12538
P356
10.1073/PNAS.94.23.12533
P407
P577
1997-11-01T00:00:00Z